Hometown: Mumbai, India
Faculty mentor: Reza Nejadnik, PhD, associate professor of pharmaceutical sciences and experimental therapeutics, College of Pharmacy
Degree program and anticipated graduation date: PhD in Pharmaceutics, 2027

Siddhanth Hejmady’s is developing a new method to predict how certain protein-based medicines, such as monoclonal antibodies, interact with each other in ways that could affect their behavior. Monoclonal antibodies are lab-made proteins that act like antibodies produced by human immune systems, destroying foreign materials. They have become an indispensable strategy in treating autoimmune diseases, cardiovascular diseases, cancer, and more. Hejmady is working with the University of Iowa Research Foundation to patent his novel experimental technique that successfully predicts how monoclonal antibodies behave in solutions. His research aims to improve the safety and quality of protein-based therapies by ensuring they remain stable over time.

Hejmady plans to join the pharmaceutical or biotechnology industry as a drug product development scientist working to deliver safe and effective medicines.

Banner location: Downtown—